Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer

References

• Owens DF, Kriegstein AR. Is there more to GABA than synaptic inhibition?. Nat Rev Neurosci 2002; 3: 715–27
   PubMed Web of Science ®Google Scholar
• Watanabe M, Maemura K, Kanbara K, Tamayama T, Hayasaki H. GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol 2002; 213: 1–47
   PubMed Web of Science ®Google Scholar
• Gilon P, Remacle C, de Varebeke J, Pauwels G, Hoet JJ. GABA content and localization of high-affinity GABA uptake during the development of the rat pancreas. Cell Mol Biol 1987; 33: 573–85
   PubMed Web of Science ®Google Scholar
• Azuma H, Inamoto T, Sakamoto T, Kiyama S, Ubai T, Shinohara Y, et al. Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism. Cancer Res 2003; 63: 8090–6
   PubMed Web of Science ®Google Scholar
• Ippolito JE, Merritt ME, Backhed F, Moulder KL, Mennerick S, Manchester JK, et al. Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers. Proc Natl Acad Sci USA 2006; 103: 12505–10
   PubMedGoogle Scholar
• Ben-Ari Y. Excitatory actions of GABA during development: The nature of the nurture. Nat Rev Neurosci 2002; 3: 728–39
   PubMed Web of Science ®Google Scholar
• Stein V, Nicoll RA. GABA generates excitement. Neuron 2003; 37: 375–8
   PubMedGoogle Scholar
• Abdul M, Hoosein NM. Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett 2002; 186: 99–106
   PubMed Web of Science ®Google Scholar
• Diaz M, Abdul M, Hoosein NM. Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2. The Prostate (Suppl.) 1998; 8: 32–6
   PubMedGoogle Scholar
• Tvrdeic A, Pericic D. Dihydroergotoxine modulation of the GABAA receptor-associated Cl- ionophore in mouse brain. Eur J Pharmacol 1992; 221: 139–43
   PubMedGoogle Scholar
• Tvrdeic A, Pericic D. Dihydrogenated ergot compounds bind with high affinity to GABAA receptor-associated Cl- ionophore. Eur J Pharmacol 1991; 202: 109–11
   PubMedGoogle Scholar
• Napoleone P, Bronzett E, Cavallotti C, Amenta F. Predominant epithelial localization of type A gamma-aminobutyric acid receptor sites within rat seminal vesicles and prostate glands. Pharmacology 1990; 41: 49–56
   PubMedGoogle Scholar
• Opolski A, Mazurkiewicz M, Wietrzyk J, Kleinrok Z, Radzikowski C. The role of GABA-ergic system in human mammary gland pathology and in growth of transplantable murine mammary cancer. J Exp Clin Cancer Res 2000; 19: 383–90
   PubMed Web of Science ®Google Scholar
• Matuszek M, Jesipowicz M, Kleinrok Z. GABA content and GAD activity in gastriccancer. Med Sci Monit 2001; 7: 377–81
   PubMedGoogle Scholar
• Kleinrok Z, Matuszek M, Jesipowicz J, Matuszek B, Opolski A, Radzikowski C. GABA content and GAD activity in colon tumors taken from patients with colon cancer or from xenografted human colon cancer cells growing as s.c. tumors in athymic nu/nu mice. J Physiol Pharmacol 1998; 49: 303–10
   PubMedGoogle Scholar
• Maemura K, Yamauchi H, Hayasaki H, Kanbara K, Tamayama T, Hirata I, et al. Gamma-amino-butyric acid immunoreactivity in intramucosal colonic tumors. J Gastroenterol Hepatol 2003; 18: 1089–94
   PubMed Web of Science ®Google Scholar
• Johnson K, Haun RS. The gamma-aminobutyric acid receptor π subunit is overexpressed in pancreatic adenocarcinomas. J Pancreas 2005; 6: 136–42
   PubMedGoogle Scholar
• Hevers W, Luddens H. The diversity of GABA A receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol 1998; 18: 35–86
   PubMedGoogle Scholar
• Bowery NG, Smart TG. GABA and glycine as neurotransmitters: A brief history. Brit J Pharmacol 2006; 147: S109–S119
   PubMed Web of Science ®Google Scholar
• Cascio M. Modulating inhibitory ligand-gated ion channels. AAPS J 2006; 8: E353–E361
   PubMedGoogle Scholar
• Boue-Garbot E., Taupignon A., Tramu G., Garret M. Molecular and electrophysiological evidence for a GABAc receptor in thyrotropin-secreting cells. Endocrinology 2000; 14: 1627–32
   Google Scholar
• Burt DR, Kamatchi GL. GABAa receptor subtypes: From pharmacology to molecular biology. FASEB J 1991; 5: 2916–23
   PubMed Web of Science ®Google Scholar
• Hosie AM, Dunne EL, Harvey RJ, Smart TG. Zinc-mediated inhibition of GABAa receptors: Discrete binding sites underlie subtype specificity. Nat Neurosci 2003; 6: 362–9
   PubMedGoogle Scholar
• Hedblom E, Kirkness EF. A novel class of GABAa receptor subunit in tissues of the reproductive system. J Biol Chem 1997; 272: 15346–50
   PubMed Web of Science ®Google Scholar
• Santhakumar V, Hanchar HJ, Wallner M, Olsen RW, Otis TS. Contributions of the GABAa receptor alpha6 subunit to phasic and tonic inhibition revealed by a naturally occurring polymorphism in the alpha6 gene. J Neurosci 2006; 26: 3357–64
   PubMedGoogle Scholar